KRPIA calls for reassessment of new drugs
Published: 2008-05-06 07:00:00
Updated: 2008-05-06 07:00:00
The Korea Research-based Pharmaceutical Industry Association (KRPIA) has urged the government to re-evaluate the ongoing assessment of antihyperlipemic agents as it failed to reflect expert opinions from related organizations.
The Health Insurance Review Agency is evaluating the economic effec...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
